Coronary Artery Disease
High genetically predicted LDL level tied to lower type 2 diabetes risk, elevated CAD risk
High genetically predicted LDL was inversely associated with risk for incident diabetes, whereas the opposite trend was observed for CAD risk, researchers reported.
Stress-prone personality tied to cardiac event risk in patients with CAD, spouses
The presence of Type D personality among patients with CAD or their spouses was associated with elevated risk for cardiac events, according to a study published in the European Journal of Preventive Cardiology.
Higher plant-to-animal protein ratio linked to lower risk for CVD, CAD among U.S. adults
A higher plant-to-animal protein ratio was associated with lower risks for CVD and CAD among adults in three ongoing U.S. prospective cohort studies, according to a study published in the American Journal of Clinical Nutrition.
Genetic risk for depression tied to heart disease risk for women, not men
Genetically predicted major depression may present in women, but not men, with increased risk for arrhythmia disorders, coronary artery disease and heart failure, and risk may vary based on menopausal status, researchers reported.
Top in endocrinology: Tirzepatide beats semaglutide; menopausal hormone therapy and CV risk
Patients with overweight or obesity assigned tirzepatide lost more weight compared with those assigned semaglutide, according to new results from the SURMOUNT-5 trial announced by Eli Lilly.
Coronary artery disease screening shows no benefit for individuals with diabetes
CHICAGO — Coronary CT angiography screening of asymptomatic adults with diabetes for coronary artery disease did not significantly lower mortality or nonfatal myocardial infarction risk, according to longer follow-up of the FACTOR-64 study.
Bioadaptor may flatten event curve after PCI, including in complex lesions
WASHINGTON — A bioadaptor implant adaptable to vessel physiology was linked to fewer target lesion failure events after 6 months compared with a drug-eluting stent, including in high-risk lesions, researchers reported.
Top in cardiology: COVID-19 linked to increased CV risk; semaglutide improves HF symptoms
Researchers found that patients with a positive SARS-CoV-2 PCR test faced an increased risk for major adverse cardiac events vs. individuals without SARS-CoV-2; this risk was even higher among patients hospitalized for COVID-19.
COVID-19 a CV risk equivalent to prior heart disease; type O blood may be protective
Prior SARS-CoV-2 infection, especially for those requiring hospitalization, was associated with increased risk for heart attack and stroke for up to 3 years, even among people with no history of heart disease, researchers reported.
FDA approves novel PET radiotracer for evaluation of suspected MI, ischemia
The FDA approved 18F flurpiridaz, a new cardiac PET perfusion radiotracer, for adult patients with known or suspected coronary artery disease being evaluated for myocardial ischemia and infarction.